Cambridge, United Kingdom

Gemma Elizabeth Mudd

This inventor holds 27 USPTO granted patents and 36 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Bicyclic Peptide Ligands. Top assignees: Bicycletx Limited, Bicyclerd Limited. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gemma Elizabeth Mudd. Retrieved from https://idiyas.com/inventor/gemma-elizabeth-mudd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.9

ph-index = 9

Forward Citations = 197(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bicyclic Peptide
CD137
PD-L1
EphA2
Nectin-4
Multimeric Ligands
Transferrin Receptor
Peptide Derivatives
Linkers
Heterotandem Complexes
P-Selectin
27 patents (USPTO):Explore Patents

Title: The Innovative Mind of Gemma Elizabeth Mudd

Introduction: Gemma Elizabeth Mudd is a pioneering inventor based in Cambridge, GB, known for her groundbreaking contributions to various fields.

Latest Patents: Gemma Elizabeth Mudd's latest patents include advancements in renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: Throughout her illustrious career, Gemma Elizabeth Mudd has received numerous awards for her innovative work, including the prestigious Inventor of the Year accolade.

Collaborations: Gemma Elizabeth Mudd has collaborated with leading research institutions, universities, and companies worldwide to further develop and implement her revolutionary inventions.

Conclusion: Gemma Elizabeth Mudd's dedication to pushing the boundaries of innovation continues to inspire future generations of inventors and shape the landscape of technology and science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…